Not applicableUnknownNCT05070832What this trial is testingHyperthermia Combined With Neoadjuvant Radiochemotherapy for LARCWho this might be right forHyperthermiaRadiotherapy Peking University Third Hospital 142
Large-scale testing (Phase 3)UnknownNCT00002747What this trial is testingSurgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth CancerWho this might be right forHead and Neck Cancer European Institute of Oncology 240
Large-scale testing (Phase 3)UnknownNCT04134897What this trial is testingNeoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal CancerWho this might be right forRectal Neoplasms MalignantRectum CarcinomaRectal Cancer Blokhin's Russian Cancer Research Center 316
Testing effectiveness (Phase 2)WithdrawnNCT03778879What this trial is testingPre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-BWho this might be right forAdenocarcinoma of the PancreasPancreas Cancer Alan Katz
Not applicableUnknownNCT04250129What this trial is testingSENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPYWho this might be right forSentinel Lymph Node Federation of Breast Diseases Societies 500
Large-scale testing (Phase 3)Study completedNCT02127645What this trial is testingNeoadjuvant Radiotherapy Followed by Transanal Endoscopic Microsurgery for T1-T2 Extraperitoneal Rectal CancerWho this might be right forRECTAL CANCER European Association for Endoscopic Surgery 25
Testing effectiveness (Phase 2)Looking for participantsNCT07005570What this trial is testingShort-course Radiotherapy Followed by Sequential Chemotherapy With or Without PD-1 Monoclonal Antibody and Bevacizumab as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer （SPARK）Who this might be right forpMMR/MSS Locally Advanced Rectal Cancer Dechang Diao 86
Not applicableUnknownNCT05739084What this trial is testingGene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STSWho this might be right forSoft Tissue Sarcomas Centre Leon Berard 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07543848What this trial is testingA Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal CancerWho this might be right forRectal NeoplasmsRectal Adenocarcinoma Chongqing University Cancer Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07018570What this trial is testingAn Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction AdenocarcinomaWho this might be right forGastroesophageal Junction (GEJ) Adenocarcinoma National Cancer Center Hospital East 26
Testing effectiveness (Phase 2)Looking for participantsNCT07182565What this trial is testingHypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction AdenocarcinomaWho this might be right forGastroesophageal Junction AdenocarcinomaHypofractionated Radiotherapy West China Hospital 84
Testing effectiveness (Phase 2)Looking for participantsNCT05965531What this trial is testingTreating Locally Advanced Rectal Cancer With TAS-102 Chemotherapy Plus Neoadjuvant RadiotherapyWho this might be right forRectal Cancer Sun Yat-sen University 65
Not applicableEnded earlyNCT01148056What this trial is testingIntensity Modulated Radiation Therapy (IMRT) for Patients With Rectal CancerWho this might be right forRectal Cancer Massachusetts General Hospital 2
Testing effectiveness (Phase 2)Looking for participantsNCT06039631What this trial is testingNeoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal CancerWho this might be right forLarynx CancerHypopharyngeal Cancer Fudan University 82
Testing effectiveness (Phase 2)WithdrawnNCT04989283What this trial is testingTesting the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung CancerWho this might be right forLung Non-Small Cell CarcinomaStage IIB Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+1 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT02679040What this trial is testingHistological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and RadiotherapyWho this might be right forBreast Cancer Institut Paoli-Calmettes 101
Testing effectiveness (Phase 2)Study completedNCT02453191What this trial is testingTVEC and Preop Radiation for Sarcoma (4 ml Dose)Who this might be right forSoft Tissue Sarcoma University of Iowa 30
Testing effectiveness (Phase 2)Study completedNCT01903408What this trial is testingRadiotherapy of the Prostate and the Pelvic Lymph Nodes After Neoadjuvant Antihormonal TreatmentWho this might be right forProstate Cancer Heidelberg University 199
Testing effectiveness (Phase 2)UnknownNCT04801511What this trial is testingPreoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal CancerWho this might be right forRectal Cancer Zhou Fuxiang 60
Not applicableLooking for participantsNCT06551909What this trial is testingRadioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)Who this might be right forGlioblastoma IRCCS San Raffaele 30